Due to the high variability of lipid and apolipoprotein composition, lipoproteins form a heterogeneous set of particles characterized by different features and metabolic fate. Lipoproteins are classified according to their density. In the healthy fasting state, established classes of lipoproteins are VLDLs, IDLs, LDLs, and HDLs (2), which can be further subdivided into lipoprotein subfractions.Not only the concentration of LDL cholesterol but also the particle size/density distribution in LDL is associated with CVDs. LDL can be differentiated into large-buoyant and small-dense LDL (lb-LDL and sd-LDL, respectively). LDL subtype patterns with predominantly sd-LDL (3) or with predominantly lb-LDL (4) are associated with an increased risk for CVDs.Although the clinical assessment of lipoprotein metabolism and risk prediction are based on simple measurements of steady-state concentrations like LDL-and HDL-cholesterol, lipoprotein metabolism is a dynamic transport process of lipids. In fact, most of the potential disease-causing effects of lipoproteins may lie yet unresolved in the transient nature of lipoprotein metabolism and lipid fluxes.LDL is primarily cleared from plasma via holoparticle uptake mediated by the LDL receptor, which requires apolipoprotein B-100 (ApoB) as a ligand. The exchange of TG and CE between lipoprotein particles is predominantly facilitated by the enzyme cholesteryl ester transfer protein (CETP). There are other enzymes and receptors besides CETP affecting LDL. Particles may lose TG and PL by the action of lipases. FC is converted to CE by the action of LCAT (5), and CE can be removed by selective CE efflux (6-9).Different enzymes hydrolyze TG in lipoproteins in plasma. The most important are LPL and HL. While LPL Abstract Lipoproteins play a key role in the development of CVD, but the dynamics of lipoprotein metabolism are difficult to address experimentally. This article describes a novel two-step combined in vitro and in silico approach that enables the estimation of key reactions in lipoprotein metabolism using just one blood sample. Lipoproteins were isolated by ultracentrifugation from fasting plasma stored at 4°C. Plasma incubated at 37°C is no longer in a steady state, and changes in composition may be determined. From these changes, we estimated rates for reactions like LCAT Human lipoprotein metabolism is highly relevant to the development of atherosclerosis and the understanding of CVD (1).The lipid-protein complex of lipoproteins consists of a core, made up of cholesteryl ester (CE), TGs, and a small proportion of free cholesterol (FC), whereas the shell consists of a phospholipid (PL) and FC monolayer. Furthermore, at least one apolipoprotein is attached to the particle.